Relationships between Salivary Melatonin Levels, Quality of Sleep, and Stress in Young Japanese Females

International Journal of Tryptophan Research

Volumn 6, Issue , 2013, Pages

  Ito, Yasuhiro ^a   Iida, Tadayuki ^b   Yamamura, Yuumi ^b   Teramura, Mayu ^b   Nakagami, Yasushi ^a   Kawai, Kaoru ^a   Nagamura, Yoichi ^c   Teradaira, Ryoji ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

anxiety; depression symptoms; salivary melatonin; sleep quality

Indexed keywords

EID: 84940520950     PISSN: None     EISSN: 11786469     Source Type: Journal    
DOI: 10.4137/IJTR.S11760     Document Type: Article

References (20)

1. Dubocovich M.L., Yun K., Al-Ghoul W.M., Benloucif S., Monica I., Masana M.I. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J. 1998; 12(12): 1211–20.
2. Tsuno N., Besset A., Ritchie K. Sleep and depression. J Clin Psychiatry. 2005; 66(10): 1254–69.
3. Michel T.M., Frangou S., Thiemeyer D. et al. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder-a postmortem study. Psychiatry Res. 2007; 151(1-2): 145–50.
4. Pal S.N., Dandiya P.C. Glutathione as a cerebral substrate in depressive behavior. Pharmacol Biochem Behav. 1994; 48(4): 845–51.
5. Doi Y., Minowa M., Okawa M., Uchiyama M. Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population. J Epidemiol. 2000; 10(2): 79–86.
6. Ashby C.R. Jr, Carr L.A., Cook C., Steptoe M.M., Franks D.D. Effect of plasma from premenstrual syndrome and control patients on human platelet and rat brain synaptosome monoamine oxidase B activity. Neuropsychobiology. 1992; 25(3): 121–5.
7. Chung S.Y., Han S.H. Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition. J Pineal Res. 2003; 34(2): 95–102.
8. Buysse D.J., Reynolds CF 3rd, Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry Res. 1989; 28(2): 193–213.
9. Spielberger C.D., Gorsuch R.L., Lushene R., Vagg P.R., Jacobs G.A. Manual for the State-Trait Anxiety Inventory STAI (Form Y). Palo Alto, CA: Consulting Psychologists Press; 1983.
10. Zung W.W.K., Richards C.B., Short M.J. Self-rating depression scale in an outpatient clinic. Arch Gen Psychiatry. 1965; 13(6): 508–15.
11. Akerstedt T., Fröberg J.E., Friberg Y., Wetterberg L. Melatonin excretion, body temperature and subjective arousal during 64 hours of sleep deprivation. Psychoneuroendocrinol. 1979; 4(3): 219–25.
12. Kato K., Hirai K., Nishiyama K. et al. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacol. 2005; 48(2): 301–10.
13. Yukuhiro N., Kimura H., Nishikawa H., Ohkawa S., Yoshikubo S., Miyamoto M. Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys. BrainRes. 2004; 19(1-2): 1027: 59–66.
14. Roth T., Stubbs C., Walsh J.K. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. Sleep. 2005; 28(3): 303–7.
15. Laitinen J.T., Saavedra J.M. Characterization of melatonin receptors in the rat suprachiasmatic nuclei: modulation of affinity with cations and guanine nucleotides. Endocrinol. 1990; 126(4): 2110–5.
16. Brown G.M. Light, melatonin and the sleep-wake cycle. J Psychiatry Neurosci. 1994; 19(5): 345–53.
17. Deacon S., Arendt J. Posture influences melatonin concentrations in plasma and saliva in humans. Neurosci Lett. 1994; 167(1-2): 191–4.
18. Lieberman H.R., Garfield G., Waldhauser F., Lynch H.J., Wurtman R.J. Possible behavioral consequences of light-induced changes in melatonin availability. Ann NY Acad Sci. 1985; 453: 242–52.
19. Voultsios A., Kennaway D.J., Dawson D. Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin. J Biol Rhythms. 1997; 12(5): 457–66.
20. Reiter R.J., Tan D.X., Poeggeler B., Menendez-Pelaez A., Chen L.D., Saarela S. Melatonin as a free radical scavenger: implications for aging and age related diseases. Ann NY Acad Sci. 1994; 719: 1–12.